News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
740,014 Results
Type
Article (44089)
Company Profile (473)
Press Release (695440)
Multimedia
Podcasts (125)
Webinars (20)
Section
Business (209474)
Career Advice (2083)
Deals (36186)
Drug Delivery (121)
Drug Development (84019)
Employer Resources (175)
FDA (16713)
Job Trends (15210)
News (354479)
Policy (33337)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2668)
Accelerated approval (37)
Adcomms (28)
Allergies (150)
Alliances (51142)
ALS (182)
Alzheimer's disease (1741)
Antibody-drug conjugate (ADC) (340)
Approvals (16953)
Artificial intelligence (560)
Autoimmune disease (167)
Automation (43)
Bankruptcy (373)
Best Places to Work (11853)
BIOSECURE Act (20)
Biosimilars (198)
Biotechnology (331)
Bladder cancer (166)
Brain cancer (61)
Breast cancer (661)
Cancer (5037)
Cardiovascular disease (428)
Career advice (1760)
Career pathing (38)
CAR-T (296)
CDC (50)
Celiac Disease (2)
Cell therapy (792)
Cervical cancer (37)
Clinical research (71568)
Collaboration (1835)
Company closure (4)
Compensation (1203)
Complete response letters (68)
COVID-19 (2785)
CRISPR (102)
C-suite (910)
Cystic fibrosis (152)
Data (6449)
Decentralized trials (2)
Denatured (40)
Depression (147)
Diabetes (509)
Diagnostics (6781)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (276)
Drug pricing (197)
Drug shortages (29)
Duchenne muscular dystrophy (249)
Earnings (91599)
Editorial (62)
Employer branding (21)
Employer resources (154)
Events (121343)
Executive appointments (1021)
FDA (19925)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1556)
Gene editing (219)
Generative AI (47)
Gene therapy (656)
GLP-1 (1016)
Government (4785)
Grass and pollen (6)
Guidances (385)
Healthcare (19257)
HIV (64)
Huntington's disease (47)
IgA nephropathy (88)
Immunology and inflammation (280)
Immuno-oncology (68)
Indications (123)
Infectious disease (3069)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (122)
Intellectual property (260)
Interviews (326)
IPO (16937)
IRA (54)
Job creations (3720)
Job search strategy (1470)
JPM (66)
Kidney cancer (17)
Labor market (86)
Layoffs (582)
Leadership (34)
Legal (8043)
Liver cancer (93)
Longevity (15)
Lung cancer (680)
Lymphoma (388)
Machine learning (43)
Management (59)
Manufacturing (835)
MASH (173)
Medical device (13943)
Medtech (14002)
Mergers & acquisitions (20336)
Metabolic disorders (1337)
Multiple sclerosis (169)
NASH (19)
Neurodegenerative disease (350)
Neuropsychiatric disorders (98)
Neuroscience (3065)
Neurotech (1)
NextGen: Class of 2026 (6795)
Non-profit (4601)
Now hiring (68)
Obesity (641)
Opinion (290)
Ovarian cancer (169)
Pain (209)
Pancreatic cancer (239)
Parkinson's disease (302)
Partnered (34)
Patents (516)
Patient recruitment (514)
Peanut (59)
People (60460)
Pharmaceutical (85)
Pharmacy benefit managers (31)
Phase 1 (22514)
Phase 2 (31551)
Phase 3 (23323)
Pipeline (5615)
Policy (309)
Postmarket research (2606)
Preclinical (9620)
Press Release (67)
Prostate cancer (256)
Psychedelics (56)
Radiopharmaceuticals (304)
Rare diseases (922)
Real estate (6071)
Recruiting (71)
Regulatory (25137)
Reports (53)
Research institute (2499)
Resumes & cover letters (358)
Rett syndrome (27)
RNA editing (21)
RSV (81)
Schizophrenia (159)
Series A (260)
Series B (203)
Service/supplier (11)
Sickle cell disease (108)
Special edition (27)
Spinal muscular atrophy (162)
Sponsored (43)
Startups (3808)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (86)
The Weekly (82)
Vaccines (1049)
Venture capital (96)
Weight loss (414)
Women's health (99)
Worklife (19)
Date
Today (158)
Last 7 days (689)
Last 30 days (2558)
Last 365 days (30811)
2026 (4393)
2025 (31075)
2024 (36304)
2023 (41035)
2022 (52291)
2021 (56775)
2020 (54970)
2019 (47478)
2018 (35755)
2017 (33054)
2016 (32399)
2015 (38439)
2014 (32219)
2013 (27146)
2012 (29263)
2011 (29914)
2010 (28046)
Location
Africa (765)
Alabama (91)
Alaska (7)
Arizona (321)
Arkansas (15)
Asia (40785)
Australia (6787)
California (11697)
Canada (3352)
China (1154)
Colorado (493)
Connecticut (507)
Delaware (344)
Europe (89522)
Florida (1735)
Georgia (367)
Hawaii (3)
Idaho (61)
Illinois (901)
India (71)
Indiana (536)
Iowa (24)
Japan (445)
Kansas (131)
Kentucky (42)
Louisiana (28)
Maine (72)
Maryland (1428)
Massachusetts (8490)
Michigan (332)
Minnesota (644)
Mississippi (5)
Missouri (131)
Montana (34)
Nebraska (28)
Nevada (124)
New Hampshire (84)
New Jersey (3109)
New Mexico (31)
New York (3058)
North Carolina (1556)
North Dakota (9)
Northern California (5709)
Ohio (346)
Oklahoma (21)
Oregon (45)
Pennsylvania (2343)
Puerto Rico (24)
Rhode Island (49)
South America (1127)
South Carolina (68)
South Dakota (1)
Southern California (4542)
Tennessee (178)
Texas (1791)
United States (41575)
Utah (348)
Vermont (1)
Virginia (274)
Washington D.C. (82)
Washington State (968)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
740,014 Results for "black diamond therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - November 6, 2025
November 6, 2025
·
1 min read
Press Releases
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 7, 2025
·
6 min read
Press Releases
Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM
December 3, 2025
·
9 min read
Deals
Servier Nabs Solid Tumor Asset in up to $780M Deal With Black Diamond
The French pharma is getting Black Diamond’s de-prioritized molecule for non-small cell lung cancers with specific mutations whose development had been paused to save money.
March 19, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 8, 2025
·
7 min read
Press Releases
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
May 29, 2025
·
1 min read
Press Releases
Black Diamond Therapeutics to Participate in Upcoming April 2025 Investor Conferences
April 1, 2025
·
1 min read
Press Releases
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025
·
8 min read
Genetown
Black Diamond Therapeutics to Participate in Jefferies 2024 Global Healthcare Conference
Black Diamond Therapeutics, Inc. announced that its Chief Executive Officer, Mark Velleca, M.D., Ph.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference taking place June 4-6, 2024, in New York, NY.
May 29, 2024
·
1 min read
Vaccines
Makary Denies FDA Plans To Levy Black Box Warning on COVID-19 Vaccines
Speaking on
Bloomberg TV
on Monday, FDA Commissioner Marty Makary contradicted recent reporting that suggested the agency was planning to add a black box label—its most serious warning—to COVID-19 vaccines.
December 16, 2025
·
3 min read
·
Heather McKenzie
1 of 74,002
Next
